Anton Wellstein


 Anton Wellstein, MD, PhD, is Associate Director of Basic Science and Director of the Biochemistry and Pharmacology Division in the Department of Oncology. His areas of expertise include control of angiogenesis in tumor growth and identification of organ homing genes of cancer metastases. 

Dr. Wellstein has received numerous grants for his work, including a grant from the Army to develop a new therapeutic paradigm for breast cancer, a two-year grant from the Komen Foundation to study pleiotrophin-ALK mediated regulation in breast cancer initiation and progression, and 5-year, $3 million award from the Department of Defense to study estrogen treatment for breast cancer.